Cambridge Trust CO Invitae Corp Transaction History
Cambridge Trust CO
- $2.6 Billion
- Q1 2024
A detailed history of Cambridge Trust CO transactions in Invitae Corp stock. As of the latest transaction made, Cambridge Trust CO holds 5,405 shares of NVTA stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,405Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVTA
# of Institutions
38Shares Held
2.12MCall Options Held
0Put Options Held
0-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA1.28MShares$02.19% of portfolio
-
Alphabet Inc. Mountain View, CA236KShares$00.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ158KShares$00.0% of portfolio
-
Eaton Vance Management Boston, MA100KShares$00.0% of portfolio
-
Nelson, Van Denburg & Campbell Wealth Management Group, LLC Omaha, NE70KShares$00.0% of portfolio
About Invitae Corp
- Ticker NVTA
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 235,266,000
- Description
- Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...